TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Paralell Pharma Oy
Closing information (x1000 NOK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
12,385
|
14,186
|
13,265 |
Financial expenses |
10
|
0 | |
Earnings before taxes |
3,671
|
1,080
|
4,497 |
Total assets |
12,639
|
15,772
|
16,893 |
Current assets |
1,681
|
2,466
|
2,597 |
Current liabilities |
382
|
497
|
651 |
Equity capital |
12,257
|
15,266
|
16,242 |
- share capital |
27
|
29
|
27 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
97.0%
|
96.8%
|
96.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
29.6%
|
7.6%
|
33.9% |
Return on assets (ROA) |
6.9%
|
26.6% | |
Current ratio |
440.1%
|
496.2%
|
398.9% |
Return on equity (ROE) |
30.0%
|
7.1%
|
27.7% |
Change turnover |
-1,099
|
172
|
2,072 |
Change turnover % |
-8%
|
1%
|
19% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.